SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Marksans Pharma - Quaterly Results

11 Aug 2023 Evaluate
The revenue zoomed 14.38% to Rs. 1820.41 millions for the quarter ended June 2023 as compared to Rs. 1591.52 millions during the corresponding quarter last year.Net Profit for the quarter ended June 2023 zoomed to 130.09% from Rs. 192.06 millions to Rs. 441.91  millions.Operating Profit saw a handsome growth to 593.81 millions from 310.39 millions in the quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1820.41 1591.52 14.38 1820.41 1591.52 14.38 6552.04 6582.89 -0.47
Other Income 326.23 194.32 67.88 326.23 194.32 67.88 604.82 422.51 43.15
PBIDT 593.81 310.39 91.31 593.81 310.39 91.31 1523.85 1559.66 -2.30
Interest 2.62 8.17 -67.93 2.62 8.17 -67.93 36.13 37.95 -4.80
PBDT 591.19 302.22 95.62 591.19 302.22 95.62 1487.72 1521.71 -2.23
Depreciation 47.24 45.18 4.56 47.24 45.18 4.56 167.37 176.63 -5.24
PBT 543.95 257.04 111.62 543.95 257.04 111.62 1320.35 1345.08 -1.84
TAX 102.04 64.98 57.03 102.04 64.98 57.03 291.69 305.20 -4.43
Deferred Tax 26.94 -0.94 -2965.96 26.94 -0.94 -2965.96 -1.71 5.04 -133.93
PAT 441.91 192.06 130.09 441.91 192.06 130.09 1028.66 1039.88 -1.08
Equity 453.16 409.31 10.71 453.16 409.31 10.71 453.16 409.31 10.71
PBIDTM(%) 32.62 19.50 67.26 32.62 19.50 67.26 23.26 23.69 -1.84

Marksans Pharma Share Price

179.55 -0.95 (-0.53%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×